Page last updated: 2024-08-22

platinum and bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)

platinum has been researched along with bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
al-Baker, S; Khokhar, AR; Perez-Soler, R; Sampedro, F; Siddik, ZH; Vadiei, K1
Khokhar, AR; Lautersztain, J; Lopez-Berestein, G; Perez-Soler, R; Schmidt, K; Siddik, ZH; Turpin, J1
Khokhar, AR; Perez-Soler, R; Siddik, ZH; Wright, K1
al-Baker, S; Han, I; Khokhar, AR; Ling, YH; Perez-Soler, R1
Han, I; Huang, L; Khokhar, AR; Mori, A; Perez-Soler, R; Wu, SP1

Other Studies

5 other study(ies) available for platinum and bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)

ArticleYear
Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the rat.
    Cancer chemotherapy and pharmacology, 1992, Volume: 30, Issue:5

    Topics: Animals; Antineoplastic Agents; Ascitic Fluid; Cisplatin; Drug Carriers; Injections, Intraperitoneal; Injections, Intravenous; Kidney; Liposomes; Liver; Male; Organoplatinum Compounds; Platinum; Rats; Rats, Inbred Strains; Spleen

1992
Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in mouse resident peritoneal macrophages, Kupffer cells, and hepatocytes.
    Cancer research, 1988, Mar-01, Volume: 48, Issue:5

    Topics: Animals; Antineoplastic Agents; In Vitro Techniques; Kupffer Cells; Liposomes; Liver; Macrophages; Male; Mice; Organoplatinum Compounds; Platinum

1988
Organ distribution and tumor uptake of liposome entrapped cis-bis-neodecanoato trans-R, R-1,2 diaminocyclohexane platinum (II) administered intravenously and into the proper hepatic artery.
    Cancer chemotherapy and pharmacology, 1988, Volume: 22, Issue:3

    Topics: Animals; Antineoplastic Agents; Cisplatin; Drug Carriers; Hepatic Artery; Infusions, Intra-Arterial; Injections, Intravenous; Liposomes; Liver Neoplasms, Experimental; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Organoplatinum Compounds; Platinum; Rabbits; Tissue Distribution

1988
Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
    Cancer research, 1993, Oct-15, Volume: 53, Issue:20

    Topics: Antineoplastic Agents; Biological Transport; Cell Survival; Cisplatin; Dimyristoylphosphatidylcholine; DNA, Neoplasm; Drug Carriers; Drug Resistance; Female; Humans; Kinetics; Liposomes; Organoplatinum Compounds; Ovarian Neoplasms; Phosphatidylglycerols; Platinum; Spectrophotometry, Atomic; Tumor Cells, Cultured

1993
In vivo antitumor activity of cis-bis-neodecanoato-trans-R,R-1, 2-diaminocyclohexane platinum(II) formulated in long-circulating liposomes.
    Cancer chemotherapy and pharmacology, 1996, Volume: 37, Issue:5

    Topics: Animals; Antineoplastic Agents; Cell Survival; Cholesterol; Drug Carriers; Female; Fibrosarcoma; G(M1) Ganglioside; Liposomes; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Organoplatinum Compounds; Phosphatidylcholines; Phosphatidylethanolamines; Platinum; Polyethylene Glycols; Solubility; Time Factors; Tissue Distribution

1996